OUR TEAM

With progressive leadership, our team is built on many years of academic and industry experience with a common goal to innovate today for a brighter, healthier tomorrow.

The Leadership

Dr. William E. Cullinan

Dean, College of Health Sciences

Dr. William Cullinan, dean of Marquette’s College of Health Sciences, is a neuroscientist focused on mental illness. An award-winning educator and mentor, he leads research and innovation in brain science and therapeutics.

Dr. David
Baker

Executive Director, 4-CYTE

Dr. David Baker, chair of Biomedical Sciences at Marquette University, focuses on developing new treatments for neuropsychiatric disorders. He is also a co-founder of Promentis Pharmaceuticals.

Dr. Bekir
Altas

Director, The Collaboratory

Dr. Altas is a neuroscientist with academic and industry experience, including drug discovery at Boehringer Ingelheim. He supports 4-CYTE’s mission to develop novel CNS therapeutics.

Dr. Sashi Kesavapany

Director, BioBridge Therepautics

Dr. Kesavapany brings 20+ years of neuroscience research and drug discovery experience, bridging academic innovation and commercial translation at Marquette.

Dr. SuJean
Choi

Director,

The Academy

Dr. Choi researches brain regulation of energy balance at Marquette, with a focus on obesity and metabolism, and mentors future scientists.

Andy
Novotny

Director,

CommUNITY Nexus

Andrew Novotny, a Marquette alum, is VP of Product Management at Direct Supply with 20+ years in healthcare tech, driving innovation to improve outcomes and reduce costs.

Nicholas
Raddatz

Manager,

4-CYTE

Raddatz manages the Baker Lab at Marquette, bringing 10+ years of lab and research experience, including prior work in drug metabolism at Array BioPharma.